Global Vaccine (Include COVID-19) Market Growth (Status and Outlook) 2026-2032
The global Vaccine (Include COVID-19) market size is predicted to grow from US$ 60590 million in 2025 to US$ 78210 million in 2032; it is expected to grow at a CAGR of 3.8% from 2026 to 2032.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and 'remember' it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the ?Vaccine (Include COVID-19) Industry Forecast? looks at past sales and reviews total world Vaccine (Include COVID-19) sales in 2025, providing a comprehensive analysis by region and market sector of projected Vaccine (Include COVID-19) sales for 2026 through 2032. With Vaccine (Include COVID-19) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccine (Include COVID-19) industry.
This Insight Report provides a comprehensive analysis of the global Vaccine (Include COVID-19) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Vaccine (Include COVID-19) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Vaccine (Include COVID-19) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccine (Include COVID-19) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccine (Include COVID-19).
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine (Include COVID-19) market by product type, application, key players and key regions and countries.
Segmentation by Type:
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and 'remember' it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the ?Vaccine (Include COVID-19) Industry Forecast? looks at past sales and reviews total world Vaccine (Include COVID-19) sales in 2025, providing a comprehensive analysis by region and market sector of projected Vaccine (Include COVID-19) sales for 2026 through 2032. With Vaccine (Include COVID-19) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccine (Include COVID-19) industry.
This Insight Report provides a comprehensive analysis of the global Vaccine (Include COVID-19) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Vaccine (Include COVID-19) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Vaccine (Include COVID-19) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccine (Include COVID-19) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccine (Include COVID-19).
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine (Include COVID-19) market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Inactivated Vaccine
- Attenuated Vaccine
- mRNA
- Other
- Public
- Private
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- CSL
- GSK
- Viatris
- AstraZeneca
- Hualan Bio
- Changchun Institute of Biological
- Sinovac
- KM Biologics
- Pfizer
- Merck
- Sinovac
- Zhejiang Pukang
- Walvax Biotechnology
- Bharat Biotech
- Serum Institute
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
- LG Life Sciences
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccine (Include COVID-19) Market Size (2021-2032)
2.1.2 Vaccine (Include COVID-19) Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Vaccine (Include COVID-19) by Country/Region (2021, 2025 & 2032)
2.2 Vaccine (Include COVID-19) Segment by Type
2.2.1 Inactivated Vaccine
2.2.2 Attenuated Vaccine
2.2.3 mRNA
2.2.4 Other
2.2.5 Vaccine (Include COVID-19) Market Size by Type
2.2.5.1 Vaccine (Include COVID-19) Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Vaccine (Include COVID-19) Market Size Market Share by Type (2021-2026)
2.3 Vaccine (Include COVID-19) Segment by Application
2.3.1 Public
2.3.2 Private
2.3.3 Vaccine (Include COVID-19) Market Size by Application
2.3.3.1 Vaccine (Include COVID-19) Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Vaccine (Include COVID-19) Market Size Market Share by Application (2021-2026)
3 VACCINE (INCLUDE COVID-19) MARKET SIZE BY PLAYER
3.1 Vaccine (Include COVID-19) Market Size Market Share by Player
3.1.1 Global Vaccine (Include COVID-19) Revenue by Player (2021-2026)
3.1.2 Global Vaccine (Include COVID-19) Revenue Market Share by Player (2021-2026)
3.2 Global Vaccine (Include COVID-19) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 VACCINE (INCLUDE COVID-19) BY REGION
4.1 Vaccine (Include COVID-19) Market Size by Region (2021-2026)
4.2 Global Vaccine (Include COVID-19) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Vaccine (Include COVID-19) Market Size Growth (2021-2026)
4.4 APAC Vaccine (Include COVID-19) Market Size Growth (2021-2026)
4.5 Europe Vaccine (Include COVID-19) Market Size Growth (2021-2026)
4.6 Middle East & Africa Vaccine (Include COVID-19) Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Vaccine (Include COVID-19) Market Size by Country (2021-2026)
5.2 Americas Vaccine (Include COVID-19) Market Size by Type (2021-2026)
5.3 Americas Vaccine (Include COVID-19) Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine (Include COVID-19) Market Size by Region (2021-2026)
6.2 APAC Vaccine (Include COVID-19) Market Size by Type (2021-2026)
6.3 APAC Vaccine (Include COVID-19) Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Vaccine (Include COVID-19) Market Size by Country (2021-2026)
7.2 Europe Vaccine (Include COVID-19) Market Size by Type (2021-2026)
7.3 Europe Vaccine (Include COVID-19) Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccine (Include COVID-19) by Region (2021-2026)
8.2 Middle East & Africa Vaccine (Include COVID-19) Market Size by Type (2021-2026)
8.3 Middle East & Africa Vaccine (Include COVID-19) Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL VACCINE (INCLUDE COVID-19) MARKET FORECAST
10.1 Global Vaccine (Include COVID-19) Forecast by Region (2027-2032)
10.1.1 Global Vaccine (Include COVID-19) Forecast by Region (2027-2032)
10.1.2 Americas Vaccine (Include COVID-19) Forecast
10.1.3 APAC Vaccine (Include COVID-19) Forecast
10.1.4 Europe Vaccine (Include COVID-19) Forecast
10.1.5 Middle East & Africa Vaccine (Include COVID-19) Forecast
10.2 Americas Vaccine (Include COVID-19) Forecast by Country (2027-2032)
10.2.1 United States Market Vaccine (Include COVID-19) Forecast
10.2.2 Canada Market Vaccine (Include COVID-19) Forecast
10.2.3 Mexico Market Vaccine (Include COVID-19) Forecast
10.2.4 Brazil Market Vaccine (Include COVID-19) Forecast
10.3 APAC Vaccine (Include COVID-19) Forecast by Region (2027-2032)
10.3.1 China Vaccine (Include COVID-19) Market Forecast
10.3.2 Japan Market Vaccine (Include COVID-19) Forecast
10.3.3 Korea Market Vaccine (Include COVID-19) Forecast
10.3.4 Southeast Asia Market Vaccine (Include COVID-19) Forecast
10.3.5 India Market Vaccine (Include COVID-19) Forecast
10.3.6 Australia Market Vaccine (Include COVID-19) Forecast
10.4 Europe Vaccine (Include COVID-19) Forecast by Country (2027-2032)
10.4.1 Germany Market Vaccine (Include COVID-19) Forecast
10.4.2 France Market Vaccine (Include COVID-19) Forecast
10.4.3 UK Market Vaccine (Include COVID-19) Forecast
10.4.4 Italy Market Vaccine (Include COVID-19) Forecast
10.4.5 Russia Market Vaccine (Include COVID-19) Forecast
10.5 Middle East & Africa Vaccine (Include COVID-19) Forecast by Region (2027-2032)
10.5.1 Egypt Market Vaccine (Include COVID-19) Forecast
10.5.2 South Africa Market Vaccine (Include COVID-19) Forecast
10.5.3 Israel Market Vaccine (Include COVID-19) Forecast
10.5.4 Turkey Market Vaccine (Include COVID-19) Forecast
10.6 Global Vaccine (Include COVID-19) Forecast by Type (2027-2032)
10.7 Global Vaccine (Include COVID-19) Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Vaccine (Include COVID-19) Forecast
11 KEY PLAYERS ANALYSIS
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Vaccine (Include COVID-19) Product Offered
11.1.3 Sanofi Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 CSL
11.2.1 CSL Company Information
11.2.2 CSL Vaccine (Include COVID-19) Product Offered
11.2.3 CSL Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 CSL Main Business Overview
11.2.5 CSL Latest Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Vaccine (Include COVID-19) Product Offered
11.3.3 GSK Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 GSK Main Business Overview
11.3.5 GSK Latest Developments
11.4 Viatris
11.4.1 Viatris Company Information
11.4.2 Viatris Vaccine (Include COVID-19) Product Offered
11.4.3 Viatris Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Viatris Main Business Overview
11.4.5 Viatris Latest Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Information
11.5.2 AstraZeneca Vaccine (Include COVID-19) Product Offered
11.5.3 AstraZeneca Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 AstraZeneca Main Business Overview
11.5.5 AstraZeneca Latest Developments
11.6 Hualan Bio
11.6.1 Hualan Bio Company Information
11.6.2 Hualan Bio Vaccine (Include COVID-19) Product Offered
11.6.3 Hualan Bio Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Hualan Bio Main Business Overview
11.6.5 Hualan Bio Latest Developments
11.7 Changchun Institute of Biological
11.7.1 Changchun Institute of Biological Company Information
11.7.2 Changchun Institute of Biological Vaccine (Include COVID-19) Product Offered
11.7.3 Changchun Institute of Biological Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Changchun Institute of Biological Main Business Overview
11.7.5 Changchun Institute of Biological Latest Developments
11.8 Sinovac
11.8.1 Sinovac Company Information
11.8.2 Sinovac Vaccine (Include COVID-19) Product Offered
11.8.3 Sinovac Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Sinovac Main Business Overview
11.8.5 Sinovac Latest Developments
11.9 KM Biologics
11.9.1 KM Biologics Company Information
11.9.2 KM Biologics Vaccine (Include COVID-19) Product Offered
11.9.3 KM Biologics Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 KM Biologics Main Business Overview
11.9.5 KM Biologics Latest Developments
11.10 Pfizer
11.10.1 Pfizer Company Information
11.10.2 Pfizer Vaccine (Include COVID-19) Product Offered
11.10.3 Pfizer Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Pfizer Main Business Overview
11.10.5 Pfizer Latest Developments
11.11 Merck
11.11.1 Merck Company Information
11.11.2 Merck Vaccine (Include COVID-19) Product Offered
11.11.3 Merck Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 Sinovac
11.12.1 Sinovac Company Information
11.12.2 Sinovac Vaccine (Include COVID-19) Product Offered
11.12.3 Sinovac Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Sinovac Main Business Overview
11.12.5 Sinovac Latest Developments
11.13 Zhejiang Pukang
11.13.1 Zhejiang Pukang Company Information
11.13.2 Zhejiang Pukang Vaccine (Include COVID-19) Product Offered
11.13.3 Zhejiang Pukang Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Zhejiang Pukang Main Business Overview
11.13.5 Zhejiang Pukang Latest Developments
11.14 Walvax Biotechnology
11.14.1 Walvax Biotechnology Company Information
11.14.2 Walvax Biotechnology Vaccine (Include COVID-19) Product Offered
11.14.3 Walvax Biotechnology Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Walvax Biotechnology Main Business Overview
11.14.5 Walvax Biotechnology Latest Developments
11.15 Bharat Biotech
11.15.1 Bharat Biotech Company Information
11.15.2 Bharat Biotech Vaccine (Include COVID-19) Product Offered
11.15.3 Bharat Biotech Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Bharat Biotech Main Business Overview
11.15.5 Bharat Biotech Latest Developments
11.16 Serum Institute
11.16.1 Serum Institute Company Information
11.16.2 Serum Institute Vaccine (Include COVID-19) Product Offered
11.16.3 Serum Institute Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Serum Institute Main Business Overview
11.16.5 Serum Institute Latest Developments
11.17 Panacea Biotec Ltd
11.17.1 Panacea Biotec Ltd Company Information
11.17.2 Panacea Biotec Ltd Vaccine (Include COVID-19) Product Offered
11.17.3 Panacea Biotec Ltd Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Panacea Biotec Ltd Main Business Overview
11.17.5 Panacea Biotec Ltd Latest Developments
11.18 Bio-Med
11.18.1 Bio-Med Company Information
11.18.2 Bio-Med Vaccine (Include COVID-19) Product Offered
11.18.3 Bio-Med Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Bio-Med Main Business Overview
11.18.5 Bio-Med Latest Developments
11.19 Halfkin Bio-Pharmaceuticals
11.19.1 Halfkin Bio-Pharmaceuticals Company Information
11.19.2 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product Offered
11.19.3 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Halfkin Bio-Pharmaceuticals Main Business Overview
11.19.5 Halfkin Bio-Pharmaceuticals Latest Developments
11.20 LG Life Sciences
11.20.1 LG Life Sciences Company Information
11.20.2 LG Life Sciences Vaccine (Include COVID-19) Product Offered
11.20.3 LG Life Sciences Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 LG Life Sciences Main Business Overview
11.20.5 LG Life Sciences Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccine (Include COVID-19) Market Size (2021-2032)
2.1.2 Vaccine (Include COVID-19) Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Vaccine (Include COVID-19) by Country/Region (2021, 2025 & 2032)
2.2 Vaccine (Include COVID-19) Segment by Type
2.2.1 Inactivated Vaccine
2.2.2 Attenuated Vaccine
2.2.3 mRNA
2.2.4 Other
2.2.5 Vaccine (Include COVID-19) Market Size by Type
2.2.5.1 Vaccine (Include COVID-19) Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Vaccine (Include COVID-19) Market Size Market Share by Type (2021-2026)
2.3 Vaccine (Include COVID-19) Segment by Application
2.3.1 Public
2.3.2 Private
2.3.3 Vaccine (Include COVID-19) Market Size by Application
2.3.3.1 Vaccine (Include COVID-19) Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Vaccine (Include COVID-19) Market Size Market Share by Application (2021-2026)
3 VACCINE (INCLUDE COVID-19) MARKET SIZE BY PLAYER
3.1 Vaccine (Include COVID-19) Market Size Market Share by Player
3.1.1 Global Vaccine (Include COVID-19) Revenue by Player (2021-2026)
3.1.2 Global Vaccine (Include COVID-19) Revenue Market Share by Player (2021-2026)
3.2 Global Vaccine (Include COVID-19) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 VACCINE (INCLUDE COVID-19) BY REGION
4.1 Vaccine (Include COVID-19) Market Size by Region (2021-2026)
4.2 Global Vaccine (Include COVID-19) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Vaccine (Include COVID-19) Market Size Growth (2021-2026)
4.4 APAC Vaccine (Include COVID-19) Market Size Growth (2021-2026)
4.5 Europe Vaccine (Include COVID-19) Market Size Growth (2021-2026)
4.6 Middle East & Africa Vaccine (Include COVID-19) Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Vaccine (Include COVID-19) Market Size by Country (2021-2026)
5.2 Americas Vaccine (Include COVID-19) Market Size by Type (2021-2026)
5.3 Americas Vaccine (Include COVID-19) Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine (Include COVID-19) Market Size by Region (2021-2026)
6.2 APAC Vaccine (Include COVID-19) Market Size by Type (2021-2026)
6.3 APAC Vaccine (Include COVID-19) Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Vaccine (Include COVID-19) Market Size by Country (2021-2026)
7.2 Europe Vaccine (Include COVID-19) Market Size by Type (2021-2026)
7.3 Europe Vaccine (Include COVID-19) Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccine (Include COVID-19) by Region (2021-2026)
8.2 Middle East & Africa Vaccine (Include COVID-19) Market Size by Type (2021-2026)
8.3 Middle East & Africa Vaccine (Include COVID-19) Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL VACCINE (INCLUDE COVID-19) MARKET FORECAST
10.1 Global Vaccine (Include COVID-19) Forecast by Region (2027-2032)
10.1.1 Global Vaccine (Include COVID-19) Forecast by Region (2027-2032)
10.1.2 Americas Vaccine (Include COVID-19) Forecast
10.1.3 APAC Vaccine (Include COVID-19) Forecast
10.1.4 Europe Vaccine (Include COVID-19) Forecast
10.1.5 Middle East & Africa Vaccine (Include COVID-19) Forecast
10.2 Americas Vaccine (Include COVID-19) Forecast by Country (2027-2032)
10.2.1 United States Market Vaccine (Include COVID-19) Forecast
10.2.2 Canada Market Vaccine (Include COVID-19) Forecast
10.2.3 Mexico Market Vaccine (Include COVID-19) Forecast
10.2.4 Brazil Market Vaccine (Include COVID-19) Forecast
10.3 APAC Vaccine (Include COVID-19) Forecast by Region (2027-2032)
10.3.1 China Vaccine (Include COVID-19) Market Forecast
10.3.2 Japan Market Vaccine (Include COVID-19) Forecast
10.3.3 Korea Market Vaccine (Include COVID-19) Forecast
10.3.4 Southeast Asia Market Vaccine (Include COVID-19) Forecast
10.3.5 India Market Vaccine (Include COVID-19) Forecast
10.3.6 Australia Market Vaccine (Include COVID-19) Forecast
10.4 Europe Vaccine (Include COVID-19) Forecast by Country (2027-2032)
10.4.1 Germany Market Vaccine (Include COVID-19) Forecast
10.4.2 France Market Vaccine (Include COVID-19) Forecast
10.4.3 UK Market Vaccine (Include COVID-19) Forecast
10.4.4 Italy Market Vaccine (Include COVID-19) Forecast
10.4.5 Russia Market Vaccine (Include COVID-19) Forecast
10.5 Middle East & Africa Vaccine (Include COVID-19) Forecast by Region (2027-2032)
10.5.1 Egypt Market Vaccine (Include COVID-19) Forecast
10.5.2 South Africa Market Vaccine (Include COVID-19) Forecast
10.5.3 Israel Market Vaccine (Include COVID-19) Forecast
10.5.4 Turkey Market Vaccine (Include COVID-19) Forecast
10.6 Global Vaccine (Include COVID-19) Forecast by Type (2027-2032)
10.7 Global Vaccine (Include COVID-19) Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Vaccine (Include COVID-19) Forecast
11 KEY PLAYERS ANALYSIS
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Vaccine (Include COVID-19) Product Offered
11.1.3 Sanofi Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 CSL
11.2.1 CSL Company Information
11.2.2 CSL Vaccine (Include COVID-19) Product Offered
11.2.3 CSL Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 CSL Main Business Overview
11.2.5 CSL Latest Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Vaccine (Include COVID-19) Product Offered
11.3.3 GSK Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 GSK Main Business Overview
11.3.5 GSK Latest Developments
11.4 Viatris
11.4.1 Viatris Company Information
11.4.2 Viatris Vaccine (Include COVID-19) Product Offered
11.4.3 Viatris Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Viatris Main Business Overview
11.4.5 Viatris Latest Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Information
11.5.2 AstraZeneca Vaccine (Include COVID-19) Product Offered
11.5.3 AstraZeneca Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 AstraZeneca Main Business Overview
11.5.5 AstraZeneca Latest Developments
11.6 Hualan Bio
11.6.1 Hualan Bio Company Information
11.6.2 Hualan Bio Vaccine (Include COVID-19) Product Offered
11.6.3 Hualan Bio Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Hualan Bio Main Business Overview
11.6.5 Hualan Bio Latest Developments
11.7 Changchun Institute of Biological
11.7.1 Changchun Institute of Biological Company Information
11.7.2 Changchun Institute of Biological Vaccine (Include COVID-19) Product Offered
11.7.3 Changchun Institute of Biological Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Changchun Institute of Biological Main Business Overview
11.7.5 Changchun Institute of Biological Latest Developments
11.8 Sinovac
11.8.1 Sinovac Company Information
11.8.2 Sinovac Vaccine (Include COVID-19) Product Offered
11.8.3 Sinovac Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Sinovac Main Business Overview
11.8.5 Sinovac Latest Developments
11.9 KM Biologics
11.9.1 KM Biologics Company Information
11.9.2 KM Biologics Vaccine (Include COVID-19) Product Offered
11.9.3 KM Biologics Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 KM Biologics Main Business Overview
11.9.5 KM Biologics Latest Developments
11.10 Pfizer
11.10.1 Pfizer Company Information
11.10.2 Pfizer Vaccine (Include COVID-19) Product Offered
11.10.3 Pfizer Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Pfizer Main Business Overview
11.10.5 Pfizer Latest Developments
11.11 Merck
11.11.1 Merck Company Information
11.11.2 Merck Vaccine (Include COVID-19) Product Offered
11.11.3 Merck Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 Sinovac
11.12.1 Sinovac Company Information
11.12.2 Sinovac Vaccine (Include COVID-19) Product Offered
11.12.3 Sinovac Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Sinovac Main Business Overview
11.12.5 Sinovac Latest Developments
11.13 Zhejiang Pukang
11.13.1 Zhejiang Pukang Company Information
11.13.2 Zhejiang Pukang Vaccine (Include COVID-19) Product Offered
11.13.3 Zhejiang Pukang Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Zhejiang Pukang Main Business Overview
11.13.5 Zhejiang Pukang Latest Developments
11.14 Walvax Biotechnology
11.14.1 Walvax Biotechnology Company Information
11.14.2 Walvax Biotechnology Vaccine (Include COVID-19) Product Offered
11.14.3 Walvax Biotechnology Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Walvax Biotechnology Main Business Overview
11.14.5 Walvax Biotechnology Latest Developments
11.15 Bharat Biotech
11.15.1 Bharat Biotech Company Information
11.15.2 Bharat Biotech Vaccine (Include COVID-19) Product Offered
11.15.3 Bharat Biotech Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Bharat Biotech Main Business Overview
11.15.5 Bharat Biotech Latest Developments
11.16 Serum Institute
11.16.1 Serum Institute Company Information
11.16.2 Serum Institute Vaccine (Include COVID-19) Product Offered
11.16.3 Serum Institute Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Serum Institute Main Business Overview
11.16.5 Serum Institute Latest Developments
11.17 Panacea Biotec Ltd
11.17.1 Panacea Biotec Ltd Company Information
11.17.2 Panacea Biotec Ltd Vaccine (Include COVID-19) Product Offered
11.17.3 Panacea Biotec Ltd Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Panacea Biotec Ltd Main Business Overview
11.17.5 Panacea Biotec Ltd Latest Developments
11.18 Bio-Med
11.18.1 Bio-Med Company Information
11.18.2 Bio-Med Vaccine (Include COVID-19) Product Offered
11.18.3 Bio-Med Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Bio-Med Main Business Overview
11.18.5 Bio-Med Latest Developments
11.19 Halfkin Bio-Pharmaceuticals
11.19.1 Halfkin Bio-Pharmaceuticals Company Information
11.19.2 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product Offered
11.19.3 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Halfkin Bio-Pharmaceuticals Main Business Overview
11.19.5 Halfkin Bio-Pharmaceuticals Latest Developments
11.20 LG Life Sciences
11.20.1 LG Life Sciences Company Information
11.20.2 LG Life Sciences Vaccine (Include COVID-19) Product Offered
11.20.3 LG Life Sciences Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 LG Life Sciences Main Business Overview
11.20.5 LG Life Sciences Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Vaccine (Include COVID-19) Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Vaccine (Include COVID-19) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Inactivated Vaccine
Table 4. Major Players of Attenuated Vaccine
Table 5. Major Players of mRNA
Table 6. Major Players of Other
Table 7. Vaccine (Include COVID-19) Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Vaccine (Include COVID-19) Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Vaccine (Include COVID-19) Market Size Market Share by Type (2021-2026)
Table 10. Vaccine (Include COVID-19) Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Vaccine (Include COVID-19) Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Vaccine (Include COVID-19) Market Size Market Share by Application (2021-2026)
Table 13. Global Vaccine (Include COVID-19) Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Vaccine (Include COVID-19) Revenue Market Share by Player (2021-2026)
Table 15. Vaccine (Include COVID-19) Key Players Head office and Products Offered
Table 16. Vaccine (Include COVID-19) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Vaccine (Include COVID-19) Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Vaccine (Include COVID-19) Market Size Market Share by Region (2021-2026)
Table 21. Global Vaccine (Include COVID-19) Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Vaccine (Include COVID-19) Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Vaccine (Include COVID-19) Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Vaccine (Include COVID-19) Market Size Market Share by Country (2021-2026)
Table 25. Americas Vaccine (Include COVID-19) Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Vaccine (Include COVID-19) Market Size Market Share by Type (2021-2026)
Table 27. Americas Vaccine (Include COVID-19) Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Vaccine (Include COVID-19) Market Size Market Share by Application (2021-2026)
Table 29. APAC Vaccine (Include COVID-19) Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Vaccine (Include COVID-19) Market Size Market Share by Region (2021-2026)
Table 31. APAC Vaccine (Include COVID-19) Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Vaccine (Include COVID-19) Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Vaccine (Include COVID-19) Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Vaccine (Include COVID-19) Market Size Market Share by Country (2021-2026)
Table 35. Europe Vaccine (Include COVID-19) Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Vaccine (Include COVID-19) Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Vaccine (Include COVID-19) Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Vaccine (Include COVID-19) Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Vaccine (Include COVID-19) Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Vaccine (Include COVID-19)
Table 41. Key Market Challenges & Risks of Vaccine (Include COVID-19)
Table 42. Key Industry Trends of Vaccine (Include COVID-19)
Table 43. Global Vaccine (Include COVID-19) Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Vaccine (Include COVID-19) Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Vaccine (Include COVID-19) Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Vaccine (Include COVID-19) Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Sanofi Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 48. Sanofi Vaccine (Include COVID-19) Product Offered
Table 49. Sanofi Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Sanofi Main Business
Table 51. Sanofi Latest Developments
Table 52. CSL Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 53. CSL Vaccine (Include COVID-19) Product Offered
Table 54. CSL Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. CSL Main Business
Table 56. CSL Latest Developments
Table 57. GSK Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 58. GSK Vaccine (Include COVID-19) Product Offered
Table 59. GSK Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. GSK Main Business
Table 61. GSK Latest Developments
Table 62. Viatris Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 63. Viatris Vaccine (Include COVID-19) Product Offered
Table 64. Viatris Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Viatris Main Business
Table 66. Viatris Latest Developments
Table 67. AstraZeneca Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 68. AstraZeneca Vaccine (Include COVID-19) Product Offered
Table 69. AstraZeneca Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. AstraZeneca Main Business
Table 71. AstraZeneca Latest Developments
Table 72. Hualan Bio Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 73. Hualan Bio Vaccine (Include COVID-19) Product Offered
Table 74. Hualan Bio Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Hualan Bio Main Business
Table 76. Hualan Bio Latest Developments
Table 77. Changchun Institute of Biological Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 78. Changchun Institute of Biological Vaccine (Include COVID-19) Product Offered
Table 79. Changchun Institute of Biological Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Changchun Institute of Biological Main Business
Table 81. Changchun Institute of Biological Latest Developments
Table 82. Sinovac Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 83. Sinovac Vaccine (Include COVID-19) Product Offered
Table 84. Sinovac Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Sinovac Main Business
Table 86. Sinovac Latest Developments
Table 87. KM Biologics Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 88. KM Biologics Vaccine (Include COVID-19) Product Offered
Table 89. KM Biologics Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. KM Biologics Main Business
Table 91. KM Biologics Latest Developments
Table 92. Pfizer Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 93. Pfizer Vaccine (Include COVID-19) Product Offered
Table 94. Pfizer Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Pfizer Main Business
Table 96. Pfizer Latest Developments
Table 97. Merck Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 98. Merck Vaccine (Include COVID-19) Product Offered
Table 99. Merck Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Merck Main Business
Table 101. Merck Latest Developments
Table 102. Sinovac Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 103. Sinovac Vaccine (Include COVID-19) Product Offered
Table 104. Sinovac Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Sinovac Main Business
Table 106. Sinovac Latest Developments
Table 107. Zhejiang Pukang Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 108. Zhejiang Pukang Vaccine (Include COVID-19) Product Offered
Table 109. Zhejiang Pukang Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Zhejiang Pukang Main Business
Table 111. Zhejiang Pukang Latest Developments
Table 112. Walvax Biotechnology Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 113. Walvax Biotechnology Vaccine (Include COVID-19) Product Offered
Table 114. Walvax Biotechnology Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. Walvax Biotechnology Main Business
Table 116. Walvax Biotechnology Latest Developments
Table 117. Bharat Biotech Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 118. Bharat Biotech Vaccine (Include COVID-19) Product Offered
Table 119. Bharat Biotech Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. Bharat Biotech Main Business
Table 121. Bharat Biotech Latest Developments
Table 122. Serum Institute Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 123. Serum Institute Vaccine (Include COVID-19) Product Offered
Table 124. Serum Institute Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 125. Serum Institute Main Business
Table 126. Serum Institute Latest Developments
Table 127. Panacea Biotec Ltd Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 128. Panacea Biotec Ltd Vaccine (Include COVID-19) Product Offered
Table 129. Panacea Biotec Ltd Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 130. Panacea Biotec Ltd Main Business
Table 131. Panacea Biotec Ltd Latest Developments
Table 132. Bio-Med Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 133. Bio-Med Vaccine (Include COVID-19) Product Offered
Table 134. Bio-Med Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 135. Bio-Med Main Business
Table 136. Bio-Med Latest Developments
Table 137. Halfkin Bio-Pharmaceuticals Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 138. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product Offered
Table 139. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 140. Halfkin Bio-Pharmaceuticals Main Business
Table 141. Halfkin Bio-Pharmaceuticals Latest Developments
Table 142. LG Life Sciences Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 143. LG Life Sciences Vaccine (Include COVID-19) Product Offered
Table 144. LG Life Sciences Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 145. LG Life Sciences Main Business
Table 146. LG Life Sciences Latest Developments
Table 1. Vaccine (Include COVID-19) Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Vaccine (Include COVID-19) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Inactivated Vaccine
Table 4. Major Players of Attenuated Vaccine
Table 5. Major Players of mRNA
Table 6. Major Players of Other
Table 7. Vaccine (Include COVID-19) Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Vaccine (Include COVID-19) Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Vaccine (Include COVID-19) Market Size Market Share by Type (2021-2026)
Table 10. Vaccine (Include COVID-19) Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Vaccine (Include COVID-19) Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Vaccine (Include COVID-19) Market Size Market Share by Application (2021-2026)
Table 13. Global Vaccine (Include COVID-19) Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Vaccine (Include COVID-19) Revenue Market Share by Player (2021-2026)
Table 15. Vaccine (Include COVID-19) Key Players Head office and Products Offered
Table 16. Vaccine (Include COVID-19) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Vaccine (Include COVID-19) Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Vaccine (Include COVID-19) Market Size Market Share by Region (2021-2026)
Table 21. Global Vaccine (Include COVID-19) Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Vaccine (Include COVID-19) Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Vaccine (Include COVID-19) Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Vaccine (Include COVID-19) Market Size Market Share by Country (2021-2026)
Table 25. Americas Vaccine (Include COVID-19) Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Vaccine (Include COVID-19) Market Size Market Share by Type (2021-2026)
Table 27. Americas Vaccine (Include COVID-19) Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Vaccine (Include COVID-19) Market Size Market Share by Application (2021-2026)
Table 29. APAC Vaccine (Include COVID-19) Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Vaccine (Include COVID-19) Market Size Market Share by Region (2021-2026)
Table 31. APAC Vaccine (Include COVID-19) Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Vaccine (Include COVID-19) Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Vaccine (Include COVID-19) Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Vaccine (Include COVID-19) Market Size Market Share by Country (2021-2026)
Table 35. Europe Vaccine (Include COVID-19) Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Vaccine (Include COVID-19) Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Vaccine (Include COVID-19) Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Vaccine (Include COVID-19) Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Vaccine (Include COVID-19) Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Vaccine (Include COVID-19)
Table 41. Key Market Challenges & Risks of Vaccine (Include COVID-19)
Table 42. Key Industry Trends of Vaccine (Include COVID-19)
Table 43. Global Vaccine (Include COVID-19) Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Vaccine (Include COVID-19) Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Vaccine (Include COVID-19) Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Vaccine (Include COVID-19) Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Sanofi Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 48. Sanofi Vaccine (Include COVID-19) Product Offered
Table 49. Sanofi Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Sanofi Main Business
Table 51. Sanofi Latest Developments
Table 52. CSL Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 53. CSL Vaccine (Include COVID-19) Product Offered
Table 54. CSL Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. CSL Main Business
Table 56. CSL Latest Developments
Table 57. GSK Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 58. GSK Vaccine (Include COVID-19) Product Offered
Table 59. GSK Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. GSK Main Business
Table 61. GSK Latest Developments
Table 62. Viatris Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 63. Viatris Vaccine (Include COVID-19) Product Offered
Table 64. Viatris Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Viatris Main Business
Table 66. Viatris Latest Developments
Table 67. AstraZeneca Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 68. AstraZeneca Vaccine (Include COVID-19) Product Offered
Table 69. AstraZeneca Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. AstraZeneca Main Business
Table 71. AstraZeneca Latest Developments
Table 72. Hualan Bio Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 73. Hualan Bio Vaccine (Include COVID-19) Product Offered
Table 74. Hualan Bio Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Hualan Bio Main Business
Table 76. Hualan Bio Latest Developments
Table 77. Changchun Institute of Biological Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 78. Changchun Institute of Biological Vaccine (Include COVID-19) Product Offered
Table 79. Changchun Institute of Biological Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Changchun Institute of Biological Main Business
Table 81. Changchun Institute of Biological Latest Developments
Table 82. Sinovac Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 83. Sinovac Vaccine (Include COVID-19) Product Offered
Table 84. Sinovac Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Sinovac Main Business
Table 86. Sinovac Latest Developments
Table 87. KM Biologics Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 88. KM Biologics Vaccine (Include COVID-19) Product Offered
Table 89. KM Biologics Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. KM Biologics Main Business
Table 91. KM Biologics Latest Developments
Table 92. Pfizer Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 93. Pfizer Vaccine (Include COVID-19) Product Offered
Table 94. Pfizer Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Pfizer Main Business
Table 96. Pfizer Latest Developments
Table 97. Merck Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 98. Merck Vaccine (Include COVID-19) Product Offered
Table 99. Merck Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Merck Main Business
Table 101. Merck Latest Developments
Table 102. Sinovac Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 103. Sinovac Vaccine (Include COVID-19) Product Offered
Table 104. Sinovac Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Sinovac Main Business
Table 106. Sinovac Latest Developments
Table 107. Zhejiang Pukang Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 108. Zhejiang Pukang Vaccine (Include COVID-19) Product Offered
Table 109. Zhejiang Pukang Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Zhejiang Pukang Main Business
Table 111. Zhejiang Pukang Latest Developments
Table 112. Walvax Biotechnology Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 113. Walvax Biotechnology Vaccine (Include COVID-19) Product Offered
Table 114. Walvax Biotechnology Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. Walvax Biotechnology Main Business
Table 116. Walvax Biotechnology Latest Developments
Table 117. Bharat Biotech Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 118. Bharat Biotech Vaccine (Include COVID-19) Product Offered
Table 119. Bharat Biotech Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. Bharat Biotech Main Business
Table 121. Bharat Biotech Latest Developments
Table 122. Serum Institute Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 123. Serum Institute Vaccine (Include COVID-19) Product Offered
Table 124. Serum Institute Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 125. Serum Institute Main Business
Table 126. Serum Institute Latest Developments
Table 127. Panacea Biotec Ltd Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 128. Panacea Biotec Ltd Vaccine (Include COVID-19) Product Offered
Table 129. Panacea Biotec Ltd Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 130. Panacea Biotec Ltd Main Business
Table 131. Panacea Biotec Ltd Latest Developments
Table 132. Bio-Med Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 133. Bio-Med Vaccine (Include COVID-19) Product Offered
Table 134. Bio-Med Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 135. Bio-Med Main Business
Table 136. Bio-Med Latest Developments
Table 137. Halfkin Bio-Pharmaceuticals Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 138. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product Offered
Table 139. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 140. Halfkin Bio-Pharmaceuticals Main Business
Table 141. Halfkin Bio-Pharmaceuticals Latest Developments
Table 142. LG Life Sciences Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 143. LG Life Sciences Vaccine (Include COVID-19) Product Offered
Table 144. LG Life Sciences Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 145. LG Life Sciences Main Business
Table 146. LG Life Sciences Latest Developments
LIST OF FIGURES
Figure 1. Vaccine (Include COVID-19) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Vaccine (Include COVID-19) Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Vaccine (Include COVID-19) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Vaccine (Include COVID-19) Sales Market Share by Country/Region (2025)
Figure 8. Vaccine (Include COVID-19) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Vaccine (Include COVID-19) Market Size Market Share by Type in 2025
Figure 10. Vaccine (Include COVID-19) in Public
Figure 11. Global Vaccine (Include COVID-19) Market: Public (2021-2026) & ($ millions)
Figure 12. Vaccine (Include COVID-19) in Private
Figure 13. Global Vaccine (Include COVID-19) Market: Private (2021-2026) & ($ millions)
Figure 14. Global Vaccine (Include COVID-19) Market Size Market Share by Application in 2025
Figure 15. Global Vaccine (Include COVID-19) Revenue Market Share by Player in 2025
Figure 16. Global Vaccine (Include COVID-19) Market Size Market Share by Region (2021-2026)
Figure 17. Americas Vaccine (Include COVID-19) Market Size 2021-2026 ($ millions)
Figure 18. APAC Vaccine (Include COVID-19) Market Size 2021-2026 ($ millions)
Figure 19. Europe Vaccine (Include COVID-19) Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Vaccine (Include COVID-19) Market Size 2021-2026 ($ millions)
Figure 21. Americas Vaccine (Include COVID-19) Value Market Share by Country in 2025
Figure 22. United States Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Vaccine (Include COVID-19) Market Size Market Share by Region in 2025
Figure 27. APAC Vaccine (Include COVID-19) Market Size Market Share by Type (2021-2026)
Figure 28. APAC Vaccine (Include COVID-19) Market Size Market Share by Application (2021-2026)
Figure 29. China Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 33. India Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Vaccine (Include COVID-19) Market Size Market Share by Country in 2025
Figure 36. Europe Vaccine (Include COVID-19) Market Size Market Share by Type (2021-2026)
Figure 37. Europe Vaccine (Include COVID-19) Market Size Market Share by Application (2021-2026)
Figure 38. Germany Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 39. France Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Vaccine (Include COVID-19) Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Vaccine (Include COVID-19) Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Vaccine (Include COVID-19) Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 52. APAC Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 53. Europe Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 55. United States Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 56. Canada Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 57. Mexico Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 58. Brazil Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 59. China Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 60. Japan Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 61. Korea Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 63. India Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 64. Australia Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 65. Germany Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 66. France Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 67. UK Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 68. Italy Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 69. Russia Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 70. Egypt Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 71. South Africa Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 72. Israel Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 73. Turkey Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 74. Global Vaccine (Include COVID-19) Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Vaccine (Include COVID-19) Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 1. Vaccine (Include COVID-19) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Vaccine (Include COVID-19) Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Vaccine (Include COVID-19) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Vaccine (Include COVID-19) Sales Market Share by Country/Region (2025)
Figure 8. Vaccine (Include COVID-19) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Vaccine (Include COVID-19) Market Size Market Share by Type in 2025
Figure 10. Vaccine (Include COVID-19) in Public
Figure 11. Global Vaccine (Include COVID-19) Market: Public (2021-2026) & ($ millions)
Figure 12. Vaccine (Include COVID-19) in Private
Figure 13. Global Vaccine (Include COVID-19) Market: Private (2021-2026) & ($ millions)
Figure 14. Global Vaccine (Include COVID-19) Market Size Market Share by Application in 2025
Figure 15. Global Vaccine (Include COVID-19) Revenue Market Share by Player in 2025
Figure 16. Global Vaccine (Include COVID-19) Market Size Market Share by Region (2021-2026)
Figure 17. Americas Vaccine (Include COVID-19) Market Size 2021-2026 ($ millions)
Figure 18. APAC Vaccine (Include COVID-19) Market Size 2021-2026 ($ millions)
Figure 19. Europe Vaccine (Include COVID-19) Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Vaccine (Include COVID-19) Market Size 2021-2026 ($ millions)
Figure 21. Americas Vaccine (Include COVID-19) Value Market Share by Country in 2025
Figure 22. United States Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Vaccine (Include COVID-19) Market Size Market Share by Region in 2025
Figure 27. APAC Vaccine (Include COVID-19) Market Size Market Share by Type (2021-2026)
Figure 28. APAC Vaccine (Include COVID-19) Market Size Market Share by Application (2021-2026)
Figure 29. China Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 33. India Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Vaccine (Include COVID-19) Market Size Market Share by Country in 2025
Figure 36. Europe Vaccine (Include COVID-19) Market Size Market Share by Type (2021-2026)
Figure 37. Europe Vaccine (Include COVID-19) Market Size Market Share by Application (2021-2026)
Figure 38. Germany Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 39. France Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Vaccine (Include COVID-19) Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Vaccine (Include COVID-19) Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Vaccine (Include COVID-19) Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Vaccine (Include COVID-19) Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 52. APAC Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 53. Europe Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 55. United States Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 56. Canada Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 57. Mexico Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 58. Brazil Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 59. China Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 60. Japan Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 61. Korea Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 63. India Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 64. Australia Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 65. Germany Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 66. France Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 67. UK Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 68. Italy Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 69. Russia Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 70. Egypt Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 71. South Africa Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 72. Israel Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 73. Turkey Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
Figure 74. Global Vaccine (Include COVID-19) Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Vaccine (Include COVID-19) Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Vaccine (Include COVID-19) Market Size 2027-2032 ($ millions)
